DIAMPA LXR 5/2.5/1000MG TAB

DIAMPA LXR is a triple-action combination tablet designed for comprehensive diabetes management. Each tablet contains Empagliflozin 5mg, Linagliptin 2.5mg, and Metformin HCL 1000mg—three potent ingredients working synergistically to help regulate blood sugar levels. Empagliflozin works by increasing glucose excretion through urine, while Linagliptin enhances insulin secretion and reduces glucagon levels. Metformin improves insulin sensitivity and decreases hepatic glucose production. This combination addresses multiple pathways in glucose metabolism, making it suitable for patients requiring intensive glycemic control. DIAMPA LXR is indicated for adults with type 2 diabetes mellitus when diet and exercise alone are insufficient. It helps reduce HbA1c levels and supports long-term cardiovascular health benefits. Take as directed by your healthcare provider. Store in a cool, dry place away from moisture and direct sunlight. Always consult your doctor before starting or adjusting dosage.